April 12, 2013
/PRNewswire-USNewswire/ -- President Obama said in his
speech "We have been a nation of dreamers and risk-takers; people who see what nobody else sees sooner than anybody else sees it. We do innovation better than anybody else -- and that makes our economy stronger. When we invest in the best ideas before anybody else does, our businesses and our workers can make the best products and deliver the best services before anybody else."
, Founding Chairman of the Board of
, attended the White House event at which President Obama announced a new federal effort to fund research that will constitute a major new Brain Mapping initiative. The SBMT Board of Directors had previously submitted a whitepaper to the White House and is part of the national dialogue about President Obama's Brain Mapping Initiative.
"SBMT and Brain Mapping Foundation are naturally well positioned in playing a significant role in President Obama's initiative. We are planning to establish a NanoBioElectronic Consortium, which will focus on integrating nanotechnology, stem cell, cellular and molecular biology, immunology, device and imaging," said
, President of the
Brain Mapping Foundation
, Director of National Center for NanoBioElectronics, and Editor of the
Textbook of Nanoneuroscience and Nanoneurosurgery
. "We are also establishing the American Board of Brain Mapping in order to certify specialists in this field and planning to have a cross disciplinary doctoral program in nanobioelectronics in collaboration with one of the most prestigious universities in the US. This will help us integrate and translate technologies across multiple disciplines into neuroscience and train new generations of cross disciplinary thinkers and scientists."
The BRAIN Initiative is going to fund research on cutting-edge technologies, which could probe and or image the brain in order to better understand its structure and neuropatho-physiology as well as breaking new ground on the treatment, cure and prevention of neurological disorders such as Alzheimer's disease, epilepsy, brain cancers and neurotrauma.